Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ji Won Park, Yoonki Hong, Chin Kook Rhee, Hye Sook Choi, Kyungjoo Kim, Kwang Ha Yoo, Ki-Suck Jung & Joo Hun Park. (2023) The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 733-743.
Read now
Read now
Stephen A. Brunton & D. Kyle Hogarth. (2023) Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns. Postgraduate Medicine 0:0, pages 1-19.
Read now
Read now
Pik-Qi Chin, Chau-Chyun Sheu, Jong-Rung Tsai, Hsu-Liang Chang, Li-Yao Lee & Chung-Yu Chen. (2022) Establishing Quality of Life in Southern Taiwan COPD Patients Using Long-Acting Bronchodilator. Patient Preference and Adherence 16, pages 875-886.
Read now
Read now
Miguel Roman-Rodriguez & Alan Kaplan. (2021) GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1709-1715.
Read now
Read now
Ioanna Tsiligianni, Kristian Jong Hoeines, Christian Jensen, Janwillem W H Kocks, Björn Ställberg, Claudia Vicente & Rudi Peché. (2021) Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD Patient. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1315-1327.
Read now
Read now
Marco Contoli, Luca Morandi, Fabiano Di Marco & Mauro Carone. (2021) A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment. Expert Opinion on Pharmacotherapy 22:4, pages 427-437.
Read now
Read now
Paola Rogliani, Beatrice Ludovica Ritondo, Mariachiara Gabriele, Mario Cazzola & Luigino Calzetta. (2020) Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings. Expert Review of Clinical Pharmacology 13:9, pages 977-990.
Read now
Read now
Ji-Ho Lee, You Hyun Park, Dae Ryong Kang, Seok Jeong Lee, Myoung Kyu Lee, Sang-Ha Kim, Suk Joong Yong & Won-Yeon Lee. (2020) Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3397-3406.
Read now
Read now
Sergey Avdeev, Zaurbek Aisanov, Vladimir Arkhipov, Andrey Belevskiy, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2019) Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1267-1280.
Read now
Read now
Articles from other publishers (16)
Janwillem Kocks, António Jorge Ferreira, Per Bakke, Onno C. P. van Schayck, Heikki Ekroos, Nikolaos Tzanakis, Stéphane Soulard, Monika Haaksma-Herczegh, Montserrat Mestres-Simon, Malena Águila-Fuentes & Didier Cataldo. (2023) Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study. npj Primary Care Respiratory Medicine 33:1.
Crossref
Crossref
Brooke Foster, Daniel Obidare‐Kolade & Michael Nagy. (2023) Assessment of primary care provider and pharmacist knowledge, comfort, and barriers to appropriate inhaled corticosteroid use in chronic obstructive pulmonary disease. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 6:4, pages 339-345.
Crossref
Crossref
Bansree Patel & Ronny Priefer. (2022) Impact of chronic obstructive pulmonary disease, lung infection, and/or inhaled corticosteroids use on potential risk of lung cancer. Life Sciences 294, pages 120374.
Crossref
Crossref
Helgo Magnussen, Sarah Lucas, Therese Lapperre, Jennifer K. Quint, Ronald J. Dandurand, Nicolas Roche, Alberto Papi, David Price & Marc Miravitlles. (2021) Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study. Respiratory Research 22:1.
Crossref
Crossref
Byron M. Thomashow, David M. Mannino, Ruth Tal-Singer & James D. Crapo. (2021) A rapidly changing understanding of COPD: World COPD Day from the COPD Foundation. American Journal of Physiology-Lung Cellular and Molecular Physiology 321:5, pages L983-L987.
Crossref
Crossref
Eimir Hurley, Sarah-Jo Sinnott, Tim McDonnell, Tim Delaney, Maire O’Connor & Charles Normand. (2020) Deciphering patterns of respiratory medication use in Ireland to target interventions appropriately: a focus on COPD. Irish Journal of Medical Science (1971 -) 190:3, pages 1103-1109.
Crossref
Crossref
P.A. Turan, O. Turan, F. Güldaval, C. Anar, G. Polat & M. Büyükşirin. (2021) Transitions between COPD groups: A cross-sectional study in Turkey. Respiratory Medicine 178, pages 106310.
Crossref
Crossref
Toral J. Parikh, Krysttel C. Stryczek, Chris Gillespie, George G. Sayre, Laura Feemster, Edmunds Udris, Barbara Majerczyk, Seppo T. Rinne, Renda Soylemez Wiener, David H. Au & Christian D. Helfrich. (2020) Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids. PLOS ONE 15:9, pages e0238511.
Crossref
Crossref
Ruxandra-Mioara Rajnoveanu, Armand-Gabriel Rajnoveanu, Andreea-Bianca Ardelean, Doina Adina Todea, Carmen-Monica Pop, Sabina Antonela Antoniu, Nicoleta Stefania Motoc, Ana Florica Chis, Ariadna Petronela Fildan & Milena Adina Man. (2020) Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve. Medicina 56:9, pages 422.
Crossref
Crossref
James D. Chalmers, Irena F. Laska, Frits M.E. Franssen, Wim Janssens, Ian Pavord, David Rigau, Melissa J. McDonnell, Nicolas Roche, Don D. Sin, Daiana Stolz, Samy Suissa, Jadwiga Wedzicha & Marc Miravitlles. (2020) Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. European Respiratory Journal 55:6, pages 2000351.
Crossref
Crossref
Alexander J. K. Wilkinson & Greg Anderson. (2020) Sustainability in Inhaled Drug Delivery. Pharmaceutical Medicine 34:3, pages 191-199.
Crossref
Crossref
O. N. Titova, N. A. Kuzubova & E. S. Lebedeva. (2020) The protective effect of beclomethasone dipropionate in the modeling of chronic obstructive pulmonary disease. Russian Pulmonology 30:1, pages 61-68.
Crossref
Crossref
Kyriakos Souliotis, Luís Silva Miguel, Georgios Hillas, Margarida Borges, Giannis Papageorgiou, Diogo Viana, Joao Malhadeiro & Stéphane Soulard. (2020) The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 14, pages 175346662092680.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, E. I. Shmelev & M. Miravitls. (2019) Withdrawal of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Russian Pulmonology 29:3, pages 334-345.
Crossref
Crossref
Daniel Dedman, Sonia J. Coton, Rebecca E. Ghosh, Wilhelmine Meeraus, Courtney Crim, Catherine Harvey, Justyna Amelio & Sarah H. Landis. (2019) Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study. Pulmonary Therapy 5:1, pages 81-95.
Crossref
Crossref
O. N. Titova, N. A. Kuzubova & E. S. Lebedeva. (2019) Anti-inflammatory effects of extrafine beclomethasone dipropionate/formoterol aerosol (Foster) on rat model of chronic obstructive pulmonary disease. Russian Pulmonology 28:6, pages 693-699.
Crossref
Crossref